...
首页> 外文期刊>Medical principles and practice: international journal of the Kuwait University, Health Science Centre >Central-Variant Posterior Reversible Encephalopathy due to Sulfasalazine: A Case Report
【24h】

Central-Variant Posterior Reversible Encephalopathy due to Sulfasalazine: A Case Report

机译:柳氮磺胺吡啶致中枢性后部可逆性脑病:一例报告

获取原文
           

摘要

Objective: To report a rare case with central-variant posterior reversible encephalopathy syndrome due to sulfasalazine. Clinical Presentation and Intervention: A 55-year-old female patient presented with seizure and acute-onset hemiparesia. Thirty days earlier, treatment with sulfasalazine was commenced in response to a diagnosis of psoriatic arthritis. Laboratory examinations were normal. Brain magnetic resonance imaging showed symmetric edema within basal ganglia and thalami with sparing of the cerebral cortices. After stopping the treatment of sulfasalazine, clinical and radiological findings regressed dramatically. Conclusion: This was a case of central-variant posterior reversible encephalopathy syndrome due to sulfasalazine, and atypical imaging findings should be kept in mind for early diagnosis.
机译:目的:报告由柳氮磺胺吡啶引起的罕见的中枢性后路可逆性脑病综合征病例。临床表现和干预措施:一名55岁的女性患者出现癫痫发作和急性发作性偏瘫。三十天前,响应银屑病关节炎的诊断,开始用柳氮磺吡啶治疗。实验室检查正常。脑磁共振成像显示基底节和丘脑内对称性水肿,并有少量大脑皮层。在停止使用柳氮磺胺吡啶的治疗后,临床和放射学结果急剧下降。结论:这是由柳氮磺胺吡啶引起的中枢性后路可逆性脑病综合征,应记住非典型影像学表现以进行早期诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号